Effective immediately, Eli Lilly is capping out-of-pocket costs on its insulin products at $35 a month. The price cap automatically applies to people with private insurance. Uninsured individuals who sign up for Eli Lilly’s insulin value savings program are also eligible.
Read the full post on Becker's Hospital Review - Healthcare News